New Report Covers Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2016

Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Synthetic Bone Graft Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Synthetic Bone Graft Substitutes pipeline products.

Complete report available @ Synthetic Bone Graft Substitutes - Medical Devices Pipeline Assessment, 2016

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Scope

- Extensive coverage of the Synthetic Bone Graft Substitutes under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Advanced Biologics, LLC Aeon Astron Corporation Agenta Biotechnologies, Inc. Allergan, Inc. Alphatec Holdings Inc Anika Therapeutics Inc Baxter International Inc Berkeley Advanced Biomaterials, Inc. Bio2 Technologies, Inc. Bone Solutions, Inc. BoneGrafix, Inc. BoneSupport AB Calcitec, Inc. Citrics Biomedical, LLC curasan AG DSM Biomedical B.V. Graftys SAS Inion Oy Innovia LLC Integra LifeSciences Holdings Corp King's College London Maxigen Biotech Inc Meta Biomed Co Ltd N2 Biomedical National Center of Innovation for Biomaterials in Orthopaedic Research NovaBone Products LLC NuVasive Inc Orthogen LLC PolyPid Ltd Promimic AB RepRegen Ltd. Revivicor Inc San Raffaele hospital Scil Technology GmbH SIRAKOSS Limited Soft Tissue Regeneration Inc Soteira Inc. Trinity College Dublin University of California San Diego University of Edinburgh University of Nottingham's School Of Pharmacy Wound Management Technologies Inc Wright Medical Group NV

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###